La Torre, Mattia
Merigliano, Chiara
Maccaroni, Klizia
Chojnowski, Alexandre
Goh, Wah Ing
Giubettini, Maria
Vernì, Fiammetta
Capanni, Cristina
Rhodes, Daniela
Wright, Graham
Burke, Brian
Soddu, Silvia
Burla, Romina
Saggio, Isabella
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG-24614)
Progeria Research Foundation (2016-67)
Sapienza Università di Roma (RP1181642E87148C, RP11916B7F20A9E3, AR2201729E35E733, AR22117A575BCFA5, Be For Erc 145)
Fondazione Italiana per la Ricerca sul Cancro (22392)
EMBO (ST fellowship 7621)
Fondazione Umberto Veronesi (TG 2019)
Fondazione Buzzati Traverso (813)
Article History
Received: 6 June 2022
Accepted: 30 August 2022
First Online: 13 September 2022
Declarations
:
: Emery-Dreifuss muscular dystrophy (EDMD2, EDMD184, carrying LMNA c.775 T > G mutation) skin fibroblasts were obtained from the BioLaM biobank. The experimental protocol was approved by the local ethics committee (Rizzoli Orthopedic Institute Ethical Committee approval Prot. Gen. 0018250–2016) and followed EU regulations.
: Not applicable.
: The authors declare no competing interests.